Most Effective Contribution to Clinical Redesign
Most Effective Contribution to Clinical Redesign

Treatment pathways are crucial for the management of patient care and should be evidence based, appropriate and relevant to the individual. More than just a protocol they should a linked series of practices which serve the specific diagnosis. With high demand for integrated pathways between services, institutions and providers there is more emphasis on changing or updating the structures and management for the benefit of patients. 

Winners of this award will be a business which has working in partnership with an NHS organisation to substantially improve the service and redesign treatments, departments or service connections in a specific area. Judges will be looking for tangible transformation in the approach to treatment with new systems and processes, recording techniques, technology and training. Evidence will be represented by improved efficiency, capacity and patient outcomes. 


  • Entrants will be a pharmaceutical, consultant, private healthcare provider or other entity outside the NHS which has made substantial changes to the treatment pathways for patients in a specific treatment area 
  • Judges are looking for evidence on projects ongoing or completed in the past 2 years up until the awards entry deadline 
  • Evidence will be based on a single project for an NHS organisation 


  • Judges are looking for innovative and ambitious redesign projects which have targets based on a clearly defined outcomes whether that be efficiency, capacity or improved treatment results.  
  • Describe the context within which a transformation or redesign was necessary.  
  • What were the goals and what tools were employed to effect change?  


  • Entrants should demonstrate tangible improvements in patient outcomes, treatment pathways and experiences as a direct result of the transformation.  
  • Judges will be giving special consideration to projects which can show results supported by evidence.  
  • How has the solution benefited the patient and helped staff overcome any difficulties? 


  • If successful has the transformation project been replicated elsewhere?  
  • Judges will be looking for potential for dissemination alongside any results provided for replication in other NHS organisations.  
  • Describe with evidence how spreading best practice has been considered in the design of the project. Have the stakeholders used the learnings in other pathways within or outside the NHS body? 


  • When designing a pathway transformation what consideration has been given to end-users including staff and patients?  
  • How has the project involved these groups to ensure the goals consider the people as well as the organisation?  
  • Has there been and follow up on the results to ensure sustained success?
  • Judges are looking for evidence of involvement including testimonials and stakeholder buy-in.


  • Value can be considered here to be return on investment of time and money where there has been a tangible result which has helped the NHS organisation save money over the long term but has also improved the capacity of staff to better manage patient care.  
  • Judges are looking for evidence of both money well spent and more qualitative results concerning efficiency and patient experience. 
Most Effective Contribution to Clinical Redesign
Most Effective Contribution to Clinical Redesign

To find out more

For entry enquiries, contact Ryan Bessent on 0207 608 9045 or email